FDA inspection
GlaxoSmithKline Biologicals: FDA inspection ending Jun 4, 2024
FDA inspection 1242355 · No Action Indicated (NAI) · Saint-Amand-Les-Eaux
Key facts
| Inspection ID | 1242355 |
|---|---|
| Firm | GlaxoSmithKline Biologicals |
| FEI number | 3014752610 |
| Address | 637 Rue Des Aulnois |
| City | Saint-Amand-Les-Eaux |
| Fiscal year | 2024 |
| Inspection end date | Jun 4, 2024 |
| Classification | No Action Indicated (NAI) |
| Project area | Vaccine, Allergenic, and Live Biotherapeutic Products |
| Product type | Biologics, Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data